Edition:
United Kingdom

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

14.13USD
4:46pm BST
Change (% chg)

$-0.04 (-0.28%)
Prev Close
$14.17
Open
$14.17
Day's High
$14.20
Day's Low
$13.81
Volume
55,303
Avg. Vol
209,467
52-wk High
$16.38
52-wk Low
$2.62

About

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE) as well as wet age-related... (more)

Overall

Beta: 2.43
Market Cap(Mil.): $903.77
Shares Outstanding(Mil.): 63.78
Dividend: --
Yield (%): --

Financials

  ADVM.OQ Industry Sector
P/E (TTM): -- 98.06 34.39
EPS (TTM): -1.12 -- --
ROI: -30.51 7.59 12.67
ROE: -32.21 8.10 17.18

Earnings vs. Estimates